Studies Refute Virus' Link to Chronic Fatigue
TUESDAY, May 31 (HealthDay News) -- A virus identified two years
ago as a possible cause of chronic fatigue syndrome now turns out
not to be the culprit, new research says.
Experts say it's a major setback in the effort to understand and
treat this mysterious and debilitating disease.
The authors of a new study published May 31 in
Science find that the so-called XMRV viral pathogen spotted
in human samples in the prior study (published by the same journal
in 2009) likely got there as a result of "genetic recombination."
That can occur in the laboratory when DNA from different viruses
In this case, two mouse viruses combined and the product of that
union then contaminated the human specimens via "reagent" compounds
used in the lab, the new research shows.
This probable contamination of the samples with XMRV in the lab
"means that this virus has no proven association" with chronic
fatigue syndrome, said Stuart LeGrice, head of the lab that
oversees all XMRV research at the U.S. National Cancer Institute,
which conducted the new study.
"I believe the evidence is incontrovertible," he added. "It doesn't rule out the possibility that there's another retrovirus [involved] but, as of right now, we're close to 100 percent certain that this eliminates the virus as a causative agent of either condition."
The study was accompanied by a rare "Expression of Concern" from
the editors of
Science. While they did not call for an outright retraction of the original paper, the editors pointedly questioned the study's validity.
According to the
Wall Street Journal, the editors of
Science have asked the authors of the 2009 paper to
voluntarily retract their paper. The authors have responded that
any retraction would be "premature," the newspaper reported.
This sequence of events began two years ago, with the
publication of a finding that about two-thirds of patients with
chronic fatigue syndrome sampled were infected with XMRV, which
stands for xenotropic murine leukemia virus-related virus. These
viruses can cause cancer and other problems in mice and they can
infect human cells in the laboratory.
At the time, the finding raised hopes that there might finally
be a concrete cause for chronic fatigue syndrome and perhaps, down
the line, treatments for the disease.
The illness affects an estimated 1 percent of people worldwide
and, as its name implies, involves crippling fatigue as well as
aching joints, headaches and various other symptoms.
Unfortunately, subsequent studies by other researchers failed to
replicate the findings.
The authors of the new study looked at blood samples from 61
people with chronic fatigue syndrome. The samples came from the
same source that had supplied samples for the 2009 study.
Forty-three of the samples had earlier been diagnosed as positive
However, this time around the researchers avoided using any lab
products derived from mice. This time, they found no evidence at
all of XMRV in any of the 61 samples.
"We're learning a very important lesson that even some commonly used reagents [compounds used in scientific experiments] contain trace amounts of contaminating mouse DNA," said LeGrice, who is head of the Center of Excellence in HIV AIDS/Cancer Virology at the National Cancer Institute. "But, using diagnostic technologies that are ultra-sensitive, we can easily pick out the contaminating material. The contaminants somehow got into the samples [but] we have to be absolutely clear that this virus was never in humans."
A second study in the same issue of the journal had similar
problems trying to replicate earlier research linking XMRV with
prostate cancer tumors, for much the same reasons. That study was
led by Jay Levy of the University of California, San Francisco.
A statement from the Chronic Fatigue and Immune Dysfunction
Syndrome (CFIDS) Association of America said that "these studies
add to the mounting number of publications that challenge the
reliability of the initial report."
The U.S. National Institutes of Health is sponsoring additional
studies on XMRV and chronic fatigue syndrome.
"We will support the outcome of those studies, whichever way they lead," the CFIDS statement said.
There's more on chronic fatigue syndrome at the
U.S. Centers for
Disease Control and Prevention.
Copyright © 2011
. All rights reserved.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.